Structure of L-Theanine
CAS No.: 3081-61-6
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
L-theanine is an amino acid found most commonly in tea leaves and binds to ionotropic glutamate receptors in the micromolar range, including the AMPA and kainate receptors and, to a lesser extent, the NMDA receptor.
Synonyms: L-Glutamic Acid γ-ethyl amide; Nγ-Ethyl-L-glutamine; NSC 21308
4.5
*For Research Use Only !
Change View
| Size | Price | VIP Price |
DE Stock US Stock |
Asia Stock Global Stock |
In Stock |
| {[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | {[ item.p_spot_brand_remark ]} 1-2 weeks {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.p_spot_brand_remark ]} 1-2 weeks {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock Inquiry - | Login - + |
Please Login or Create an Account to: See VIP prices and availability
Asia Stock: Ship in 3-5 business days
EU Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
{[ item.p_spot_brand_remark ]}
1-2weeks
Inquiry
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ item.p_spot_brand_remark ]}
1-2weeks
Inquiry
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
Asia Stock: Ship in 3-5 business days
EU Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
| CAS No. : | 3081-61-6 |
| Formula : | C7H14N2O3 |
| M.W : | 174.20 |
| SMILES Code : | O=C(O)[C@@H](N)CCC(NCC)=O |
| Synonyms : |
L-Glutamic Acid γ-ethyl amide; Nγ-Ethyl-L-glutamine; NSC 21308
|
| MDL No. : | MFCD00059653 |
| InChI Key : | DATAGRPVKZEWHA-YFKPBYRVSA-N |
| Pubchem ID : | 439378 |
| GHS Pictogram: |
|
| Signal Word: | Warning |
| Hazard Statements: | H317 |
| Precautionary Statements: | P261-P280 |
In Vitro:
|
Cell Line
|
Concentration | Treated Time | Description | References |
| Tea plant seedlings | 0.1, 1, 5 mM | 14 days | Theanine inhibited lateral root development | Hortic Res. 2022 Dec 2;10(2):uhac267 |
| Arabidopsis seedlings | 0.01, 0.1, 1, 5 mM | 2 days | Theanine inhibited lateral root development | Hortic Res. 2022 Dec 2;10(2):uhac267 |
| B16F10 murine melanoma cells | 0.6-3 mM | 24 hours | To evaluate the effects of L-theanine on melanogenesis, results showed that L-theanine significantly reduced intracellular tyrosinase activity and melanin content. | Molecules. 2025 Feb 19;30(4):956 |
| AML12 cells | 1-4 mM | 24 hours | Theanine significantly alleviated OA-induced steatosis in AML12 cells and reduced intracellular TG levels. | Nutr Metab (Lond). 2022 Apr 15;19(1):29 |
| HepG2 cells | 1-4 mM | 24 hours | Theanine significantly alleviated OA-induced steatosis in HepG2 cells and reduced intracellular TG levels. | Nutr Metab (Lond). 2022 Apr 15;19(1):29 |
| Rat primary chondrocytes | 50, 100, 200 µM | 24 hours | L-theanine dose-dependently decreased mRNA and protein levels of MMP-3 and MMP-13, as well as the expression of COX-2 and iNOS in IL-1β-stimulated chondrocytes, and reduced the secretion of PGE-2 and NO in the culture supernatant. | Nutrients. 2020 Jul 3;12(7):1988 |
| Botrytis cinerea | 5 mM | 7 days | To evaluate the antifungal activity of theanine against Botrytis cinerea in vitro. Results showed that 5 mmol L−1 theanine treatment significantly inhibited the mycelial growth of B. cinerea, reducing the colony diameter by 18%. | Food Chem X. 2024 Aug 24;23:101772 |
In Vivo:
|
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
| Zebrafish | Zebrafish larvae | Added to culture media | <2 mg/mL | 48 hours | To evaluate the inhibitory effect of L-theanine on melanogenesis in zebrafish, results showed that L-theanine significantly reduced melanin production. | Molecules. 2025 Feb 19;30(4):956 |
| Tea plant | Seedlings | Hydroponic solution | 1 mM | 14 days | Theanine inhibited lateral root development by modulating H2O2 accumulation | Hortic Res. 2022 Dec 2;10(2):uhac267 |
| C57BL/6J mice | Myocardial ischemia-reperfusion injury model | Intraperitoneal injection | 10 mg/kg | Once daily for seven days | Theanine attenuates myocardial ischemia-reperfusion injury by suppressing oxidative stress and apoptosis, partially through activation of the JAK2/STAT3 signaling pathway. | Mol Med. 2024 Jun 28;30(1):98 |
| Male Sprague Dawley rats | Adolescent THC exposure model | Intraperitoneal injection | 10 mg/kg | Twice daily from P35 to P45 | L-theanine pretreatment before adolescent THC exposure is capable of preventing long-term, THC-induced dysregulation of both PFC and VTA DAergic activity states, a neuroprotective effect that persists into adulthood. In addition, pretreatment with L-theanine blocked THC-induced down-regulation of local GSK-3 (glycogen synthase kinase 3) and Akt signaling pathways directly in the PFC, two biomarkers previously associated with cannabis-related psychiatric risk and subcortical DAergic dysregulation. Finally, L-theanine powerfully blocked the development of both affective and cognitive abnormalities commonly associated with adolescent THC exposure, further demonstrating functional and long-term neuroprotective effects of L-theanine in the mesocorticolimbic system. | J Neurosci. 2021 Jan 27;41(4):739-750 |
| C57BL/6 mice | IMQ-induced psoriasis like skin inflammation model | Topical application | 10 mM or 100 mM | Twice per day for five consecutive days | Theanine significantly alleviated IMQ-induced psoriasis like skin inflammation, reducing epidermal thickness and inflammatory response | Front Pharmacol. 2021 Jul 26;12:719842 |
| Tea plants (Camellia sinensis L.) | Salt stress model | Nutrient solution treatment | 10 mM theanine | 3 days | Theanine improves salt stress tolerance via modulating redox homeostasis in tea plants | Front Plant Sci. 2021 Oct 15;12:770398 |
| C57BL/6 male mice | Acute alcoholic intestinal injury model | Oral | 100, 200, and 400 mg/kg/day | Once daily for 28 days | Theanine mitigates acute alcoholic intestinal injury by activating the HIF-1 signaling pathway to regulate the TLR4/NF-κB/HIF-1α axis. | Nutrients. 2025 Feb 18;17(4):720 |
| Mice | Healthy mice | Gavage | 100, 300, 400 mg/kg/d | Once daily for 28 days | LTA supplementation not only affects serum alkaline phosphatase (AKP), total protein (TP), and urea nitrogen (BUN) levels, but it also upregulates the mRNA and protein expression of amino acid transporters (EAAT3, EAAT1, 4F2hc, y+LAT1, CAT1, ASCT2, and B0AT1), and activates the mTOR signaling pathway. | Nutrients. 2022 Dec 28;15(1):142 |
| Mice | DdY mice | Drinking water | 20 µg/mL | Continued for 6 months | Theanine intake significantly suppressed adrenal hypertrophy in the group-housed older mice and reduced the expression of holo-GR and Dnmt3a in the hippocampus, potentially reversing the repressed state of Npas4 transcription. | Int J Mol Sci. 2023 Feb 16;24(4):3983 |
| Sprague-Dawley rats | Doxorubicin-induced ovarian toxicity model | Oral gavage | 200 mg/kg and 400 mg/kg | Once daily for 3 days | To investigate the protective effects of theanine on doxorubicin-induced ovarian toxicity, results showed that theanine ameliorated ovarian damage by reducing oxidative stress, inflammation, and endoplasmic reticulum stress. | Food Sci Nutr. 2025 Apr 24;13(4):e70150 |
| Spontaneously hypertensive rats | Spontaneously hypertensive rats | Oral | 27 µg/mL | Free access to drinking, for 6 weeks | L-theanine contributes to the prevention of bladder dysfunctions by inhibiting chronic sympathetic hyperactivity and protecting bladder contractility | Metabolites. 2021 Nov 14;11(11):778 |
| Wistar rats | Vincristine-induced neuropathy model | Intraperitoneal injection | 30, 100, and 300 mg/kg/day | Once daily for 21 days | Theanine significantly alleviated vincristine-induced neuropathy, including hyperalgesia, allodynia, and nerve functional loss, through its antioxidative, calcium homeostasis, anti-inflammatory, anti-apoptotic, and neuroprotective properties. | Antioxidants (Basel). 2023 Mar 25;12(4):803 |
| C57BL/6J mice | High-fat diet-induced nonalcoholic fatty liver model | Gavage | 300 mg/kg | Once daily for 16 weeks | Theanine significantly reduced body weight gain, hepatic steatosis, and serum levels of ALT, AST, TG, and LDL-C in HFD-induced mice. | Nutr Metab (Lond). 2022 Apr 15;19(1):29 |
| Strawberry (Fragaria × ananassa Duch. cv. 'Hongyan') | Botrytis cinerea inoculation model | Immersion | 5 mM | Single treatment, lasting 5 days | To evaluate the effect of theanine on controlling gray mold in strawberries. Results showed that 5 mmol L?1 theanine treatment significantly reduced the disease incidence and severity of gray mold and maintained higher fruit firmness. | Food Chem X. 2024 Aug 24;23:101772 |
| Caenorhabditis elegans | Ultraviolet C (UVC)-exposed nematode model | Administered via K agar plates | 50 µg/mL | Continuous for 48 hours | L-theanine treatment enhanced the removal of mtDNA damage and extended lifespan by activating autophagy, mitophagy, mitochondrial dynamics, and mitochondrial unfolded protein response (UPRmt) in UVC-exposed nematodes. | Molecules. 2024 Jun 6;29(11):2691 |
| Sprague Dawley (SD) rats | Anterior cruciate ligament transection (ACLT)-induced osteoarthritis model | Oral gavage | 50, 100, 200 mg/kg | Once daily for 6 weeks | L-theanine significantly alleviated ACLT-induced OA lesions, reduced OARSI scores, decreased serum levels of C2C and CTX-II, and lowered the expression of COX-2, PGE-2, iNOS, and NO. | Nutrients. 2020 Jul 3;12(7):1988 |
| Mice | Stress-loaded mouse model | Oral | 6 mg/kg | Two months | Theanine intake improved depression-like behavior in stress-loaded mice and modulated hippocampal metabolite levels. | Int J Mol Sci. 2020 Dec 28;22(1):193 |
| Mice | SAMP10 and ddY mice | Oral | 6 mg/kg | Continuous intake | Theanine intake suppressed stress-induced brain atrophy and altered the expression of Npas4 and Lcn2. | Nutrients. 2020 Jan 8;12(1):174 |
| C57BL/6J male mice | High-fat diet-induced obese mouse model | Gavage | 900 mg/kg | Once daily for 26 weeks | Theanine ameliorates obesity-related complications induced by high-fat diet in mice by suppressing lipid metabolism and inflammation pathways, including reducing body weight gain, fat deposition, glycolipid metabolism disorders, and hepatic steatosis. | Foods. 2024 Sep 19;13(18):2977 |
| ICR mice and SD rats | Pentobarbital-induced sleep model and caffeine-induced wakefulness model | Oral | GABA/ L-theanine mixture (100/20 mg/kg) | Sleep latency and duration were measured 40 minutes after administration | The GABA/theanine mixture significantly reduced sleep latency and increased sleep duration, showing synergistic effects compared to GABA or theanine alone. | Pharm Biol. 2019 Dec;57(1):65-73 |
| Balb/c mice | Caffeine-induced sleep disturbance model and pentobarbital-induced sleep model | Intraperitoneal injection | L-theanine (20 mg/kg), Mg-T1 (21.74 mg/kg), Mg-T2 (24.39 mg/kg) | Single administration | To investigate the effects of Mg-L-theanine complexes on sleep quality and brain electrical activity. Results showed that Mg-L-theanine complexes, especially those with higher magnesium concentrations, significantly increased the expression of GABAergic, serotonergic, and glutamatergic receptors, decreased ECoG frequency, increased amplitude, enhanced delta wave power, and increased dopamine, serotonin, and melatonin levels while decreasing MDA and increasing antioxidant enzyme levels. | Front Nutr. 2022 Apr 5;9:874254 |
| Bio Calculators | ||||
| Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
5.74mL 1.15mL 0.57mL |
28.70mL 5.74mL 2.87mL |
57.41mL 11.48mL 5.74mL |
|
| Dissolving Methods |
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
|
|||
Tags: L-Theanine | L-Glutamic Acid γ-ethyl amide | Nγ-Ethyl-L-glutamine | Apoptosis | Endogenous Metabolite | Reactive Oxygen Species | neuroprotective | anticancer | anti-oxidative | anti-stress | glutathione | GSH | 3081-61-6 |
Precautionary Statements-General | |
| Code | Phrase |
| P101 | If medical advice is needed,have product container or label at hand. |
| P102 | Keep out of reach of children. |
| P103 | Read label before use |
Prevention | |
| Code | Phrase |
| P201 | Obtain special instructions before use. |
| P202 | Do not handle until all safety precautions have been read and understood. |
| P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
| P211 | Do not spray on an open flame or other ignition source. |
| P220 | Keep/Store away from clothing/combustible materials. |
| P221 | Take any precaution to avoid mixing with combustibles |
| P222 | Do not allow contact with air. |
| P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
| P230 | Keep wetted |
| P231 | Handle under inert gas. |
| P232 | Protect from moisture. |
| P233 | Keep container tightly closed. |
| P234 | Keep only in original container. |
| P235 | Keep cool |
| P240 | Ground/bond container and receiving equipment. |
| P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
| P242 | Use only non-sparking tools. |
| P243 | Take precautionary measures against static discharge. |
| P244 | Keep reduction valves free from grease and oil. |
| P250 | Do not subject to grinding/shock/friction. |
| P251 | Pressurized container: Do not pierce or burn, even after use. |
| P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
| P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
| P262 | Do not get in eyes, on skin, or on clothing. |
| P263 | Avoid contact during pregnancy/while nursing. |
| P264 | Wash hands thoroughly after handling. |
| P265 | Wash skin thouroughly after handling. |
| P270 | Do not eat, drink or smoke when using this product. |
| P271 | Use only outdoors or in a well-ventilated area. |
| P272 | Contaminated work clothing should not be allowed out of the workplace. |
| P273 | Avoid release to the environment. |
| P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
| P281 | Use personal protective equipment as required. |
| P282 | Wear cold insulating gloves/face shield/eye protection. |
| P283 | Wear fire/flame resistant/retardant clothing. |
| P284 | Wear respiratory protection. |
| P285 | In case of inadequate ventilation wear respiratory protection. |
| P231 + P232 | Handle under inert gas. Protect from moisture. |
| P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
| Code | Phrase |
| P301 | IF SWALLOWED: |
| P304 | IF INHALED: |
| P305 | IF IN EYES: |
| P306 | IF ON CLOTHING: |
| P307 | IF exposed: |
| P308 | IF exposed or concerned: |
| P309 | IF exposed or if you feel unwell: |
| P310 | Immediately call a POISON CENTER or doctor/physician. |
| P311 | Call a POISON CENTER or doctor/physician. |
| P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
| P313 | Get medical advice/attention. |
| P314 | Get medical advice/attention if you feel unwell. |
| P315 | Get immediate medical advice/attention. |
| P320 | |
| P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
| P321 | |
| P322 | |
| P330 | Rinse mouth. |
| P331 | Do NOT induce vomiting. |
| P332 | IF SKIN irritation occurs: |
| P333 | If skin irritation or rash occurs: |
| P334 | Immerse in cool water/wrap n wet bandages. |
| P335 | Brush off loose particles from skin. |
| P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
| P337 | If eye irritation persists: |
| P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
| P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
| P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
| P342 | If experiencing respiratory symptoms: |
| P350 | Gently wash with plenty of soap and water. |
| P351 | Rinse cautiously with water for several minutes. |
| P352 | Wash with plenty of soap and water. |
| P353 | Rinse skin with water/shower. |
| P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
| P361 | Remove/Take off immediately all contaminated clothing. |
| P362 | Take off contaminated clothing and wash before reuse. |
| P363 | Wash contaminated clothing before reuse. |
| P370 | In case of fire: |
| P371 | In case of major fire and large quantities: |
| P372 | Explosion risk in case of fire. |
| P373 | DO NOT fight fire when fire reaches explosives. |
| P374 | Fight fire with normal precautions from a reasonable distance. |
| P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
| P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
| P378 | |
| P380 | Evacuate area. |
| P381 | Eliminate all ignition sources if safe to do so. |
| P390 | Absorb spillage to prevent material damage. |
| P391 | Collect spillage. Hazardous to the aquatic environment |
| P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
| P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
| P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
| P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
| P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
| P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
| P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
| P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
| P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
| P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
| P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
| P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
| P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
| P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
| P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
| P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
| P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
| P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
| P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
| P370 + P376 | In case of fire: Stop leak if safe to Do so. |
| P370 + P378 | In case of fire: |
| P370 + P380 | In case of fire: Evacuate area. |
| P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
| P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
| Code | Phrase |
| P401 | |
| P402 | Store in a dry place. |
| P403 | Store in a well-ventilated place. |
| P404 | Store in a closed container. |
| P405 | Store locked up. |
| P406 | Store in corrosive resistant/ container with a resistant inner liner. |
| P407 | Maintain air gap between stacks/pallets. |
| P410 | Protect from sunlight. |
| P411 | |
| P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
| P413 | |
| P420 | Store away from other materials. |
| P422 | |
| P402 + P404 | Store in a dry place. Store in a closed container. |
| P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
| P403 + P235 | Store in a well-ventilated place. Keep cool. |
| P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
| P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
| P411 + P235 | Keep cool. |
Disposal | |
| Code | Phrase |
| P501 | Dispose of contents/container to ... |
| P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
| Code | Phrase |
| H200 | Unstable explosive |
| H201 | Explosive; mass explosion hazard |
| H202 | Explosive; severe projection hazard |
| H203 | Explosive; fire, blast or projection hazard |
| H204 | Fire or projection hazard |
| H205 | May mass explode in fire |
| H220 | Extremely flammable gas |
| H221 | Flammable gas |
| H222 | Extremely flammable aerosol |
| H223 | Flammable aerosol |
| H224 | Extremely flammable liquid and vapour |
| H225 | Highly flammable liquid and vapour |
| H226 | Flammable liquid and vapour |
| H227 | Combustible liquid |
| H228 | Flammable solid |
| H229 | Pressurized container: may burst if heated |
| H230 | May react explosively even in the absence of air |
| H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
| H240 | Heating may cause an explosion |
| H241 | Heating may cause a fire or explosion |
| H242 | Heating may cause a fire |
| H250 | Catches fire spontaneously if exposed to air |
| H251 | Self-heating; may catch fire |
| H252 | Self-heating in large quantities; may catch fire |
| H260 | In contact with water releases flammable gases which may ignite spontaneously |
| H261 | In contact with water releases flammable gas |
| H270 | May cause or intensify fire; oxidizer |
| H271 | May cause fire or explosion; strong oxidizer |
| H272 | May intensify fire; oxidizer |
| H280 | Contains gas under pressure; may explode if heated |
| H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
| H290 | May be corrosive to metals |
Health hazards | |
| Code | Phrase |
| H300 | Fatal if swallowed |
| H301 | Toxic if swallowed |
| H302 | Harmful if swallowed |
| H303 | May be harmful if swallowed |
| H304 | May be fatal if swallowed and enters airways |
| H305 | May be harmful if swallowed and enters airways |
| H310 | Fatal in contact with skin |
| H311 | Toxic in contact with skin |
| H312 | Harmful in contact with skin |
| H313 | May be harmful in contact with skin |
| H314 | Causes severe skin burns and eye damage |
| H315 | Causes skin irritation |
| H316 | Causes mild skin irritation |
| H317 | May cause an allergic skin reaction |
| H318 | Causes serious eye damage |
| H319 | Causes serious eye irritation |
| H320 | Causes eye irritation |
| H330 | Fatal if inhaled |
| H331 | Toxic if inhaled |
| H332 | Harmful if inhaled |
| H333 | May be harmful if inhaled |
| H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
| H335 | May cause respiratory irritation |
| H336 | May cause drowsiness or dizziness |
| H340 | May cause genetic defects |
| H341 | Suspected of causing genetic defects |
| H350 | May cause cancer |
| H351 | Suspected of causing cancer |
| H360 | May damage fertility or the unborn child |
| H361 | Suspected of damaging fertility or the unborn child |
| H361d | Suspected of damaging the unborn child |
| H362 | May cause harm to breast-fed children |
| H370 | Causes damage to organs |
| H371 | May cause damage to organs |
| H372 | Causes damage to organs through prolonged or repeated exposure |
| H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
| Code | Phrase |
| H400 | Very toxic to aquatic life |
| H401 | Toxic to aquatic life |
| H402 | Harmful to aquatic life |
| H410 | Very toxic to aquatic life with long-lasting effects |
| H411 | Toxic to aquatic life with long-lasting effects |
| H412 | Harmful to aquatic life with long-lasting effects |
| H413 | May cause long-lasting harmful effects to aquatic life |
| H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL


